Minerva Surgical, Inc. (UTRS) reported Q2 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.47 million.
Minerva Surgical, Inc. (UTRS) reported Q2 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.47 million.